Covid-19 Research

Open Access
Opinion
OCLC

Introduction to One Drop of Body Fluid - PCR (1DF-PCR) Google Scholar

Read • Cite • Share — permanent Open Access hosting with DOI tracking

Kuo-Ping Chiu*

Volume3-Issue12
Dates: Received: 2022-12-20 | Accepted: 2022-12-30 | Published: 2022-12-31
Pages: 1565-1566

Abstract

It is an attractive idea to make a single drop of blood sufficient for the diagnosis of many diseases. This was exactly what the biotech company Theranos Inc., founded in 2003 by a 19-year-old girl, Elizabeth Holmes, claimed. Unfortunately, their health technology turned out to be a fraud, and Elizabeth was charged by the U.S.

FullText HTML FullText PDF DOI: 10.37871/jbres1636


Certificate of Publication




Copyright

© 2022 Kuo-Ping C. Distributed under Creative Commons CC-BY 4.0

How to cite this article

Kuo-Ping C. Introduction to One-Drop-of-Body-Fluid-PCR (1DF-PCR). 2022 Dec 31; 3(12): 1565-1566. doi: 10.37871/jbres1636, Article ID: JBRES1636, Available at: https://www.jelsciences.com/articles/jbres1636.pdf


Subject area(s)

References



Comments


Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable